Microglia/macrophages promote glioma progression

Gliomas are highly aggressive and accompanied by numerous microglia/macrophages (MG/MP) in and about the tumor. Little is known about what MG/MP do in this setting, or whether modulating MG/MP activation might affect glioma progression. Here, we used a glioma‐microglia in culture system to establish the effects the tumor and microglia have on each other. We assessed glioma progression in vivo after MG/MP ablation or in the setting of exaggerated MG/MP activation. We show that glioma cells activate microglia but inhibit their phagocytic activities. Local ablation of MG/MP in vivo decreased tumor size and improved survival curves. Conversely, pharmacological activation of MG/MP increased glioma size through stimulating tumor proliferation and inhibiting apoptosis. In agreement with recent reports, expression of the chemokine CCL21 is enhanced after MG/MP activation and correlates with tumor growth. Taken together, our findings demonstrate that inhibition of MG/MP activation may constitute a new and effective contribution towards suppressing glioma proliferation. © 2010 Wiley‐Liss, Inc.

[1]  M. Luczak,et al.  Tuftsin induced tumor necrosis activity , 1987, Molecular and Cellular Biochemistry.

[2]  C. Siao,et al.  Tissue Plasminogen Activator Mediates Microglial Activation via Its Finger Domain through Annexin II , 2002, The Journal of Neuroscience.

[3]  J. Pollard Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[4]  F. Heppner,et al.  Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion , 2009, Proceedings of the National Academy of Sciences.

[5]  A. Wesołowska,et al.  Microglia-derived TGF-β as an important regulator of glioblastoma invasion—an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor , 2008, Oncogene.

[6]  Brian D. Ross,et al.  Experimental Gliosarcoma Induces Chemokine Receptor Expression in Rat Brain , 2000, Experimental Neurology.

[7]  S. Thanos,et al.  Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  I. Siemion,et al.  Tuftsin: On the 30-year anniversary of Victor Najjar’s discovery , 1999, Peptides.

[9]  R. Nitsch,et al.  Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1 , 2001, Nature Cell Biology.

[10]  D. Constam,et al.  Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. , 1992, Journal of immunology.

[11]  S. Tsirka,et al.  Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus , 1998, Current Biology.

[12]  W. Roa,et al.  Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation , 2002, Acta Neuropathologica.

[13]  H. Kettenmann,et al.  Secondary Lymphoid Tissue Chemokine (CCL21) Activates CXCR3 to Trigger a Cl− Current and Chemotaxis in Murine Microglia1 , 2002, The Journal of Immunology.

[14]  M. Esiri,et al.  Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease 1. Gliomas , 1991, Journal of the Neurological Sciences.

[15]  E. Ranheim,et al.  Tumoricidal Effects of Activated Macrophages in a Mouse Model of Chronic Lymphocytic Leukemia1 , 2009, The Journal of Immunology.

[16]  Melody A Swartz,et al.  Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. , 2007, Cancer cell.

[17]  S. Futaki,et al.  Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity. , 1987, The Journal of biological chemistry.

[18]  P. Allavena,et al.  The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance , 2008, Immunological reviews.

[19]  M. Luczak,et al.  Suppression of Friend virus-induced leukaemia in mice by tuftsin. , 1986, The Journal of general virology.

[20]  F. D. De Braud,et al.  Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  T. Marunouchi,et al.  Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. , 1993, Journal of immunology.

[22]  M. Graeber,et al.  Microglia only weakly present glioma antigen to cytotoxic T cells , 1999, International Journal of Developmental Neuroscience.

[23]  A. Sauter,et al.  Ischemia‐induced neuronal expression of the microglia attracting chemokine secondary lymphoid‐tissue chemokine (SLC) , 2001, Glia.

[24]  P. Allavena,et al.  Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production. , 2005, Cancer research.

[25]  Zhijin Wu,et al.  Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma , 2008, Molecular Cancer Therapeutics.

[26]  Michael Platten,et al.  Glioma Cell Invasion: Regulation of Metalloproteinase Activity by TGF-β , 2001, Journal of Neuro-Oncology.

[27]  Werner Paulus,et al.  Microglia promote glioma migration , 2002, Acta Neuropathologica.

[28]  Martine M. Mirrione,et al.  Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice , 2010, Neurobiology of Disease.

[29]  J. Lafuente,et al.  Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-β (PDGFR-β) in human gliomas , 1999, Journal of Molecular Neuroscience.

[30]  B. Badie,et al.  Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas , 2002, Journal of Neuroimmunology.

[31]  W. Hickey,et al.  Contents , 2004, Journal of Neuro-Oncology.

[32]  P. Allavena,et al.  Tumor‐associated macrophages (TAM) as major players of the cancer‐related inflammation , 2009, Journal of leukocyte biology.

[33]  J. Julien,et al.  Increased glioma growth in mice depleted of macrophages. , 2007, Cancer research.

[34]  G. Gromo,et al.  The macrophage-activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro , 1994, Infection and immunity.

[35]  S. Goswami,et al.  Interleukin‐6‐Mediated Autocrine Growth Promotion in Human Glioblastoma Multiforme Cell Line U87MG , 1998, Journal of neurochemistry.

[36]  Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis , 2007, BMC immunology.

[37]  T. Roszman,et al.  T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. , 1997, Journal of immunology.

[38]  S. Tsirka,et al.  Tuftsin Fragment 1–3 Is Beneficial When Delivered After the Induction of Intracerebral Hemorrhage , 2005, Stroke.

[39]  A. Barnekow,et al.  Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor , 1998, Journal of Neuro-Oncology.

[40]  A. Wesołowska,et al.  Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. , 2008, Oncogene.

[41]  A. Cerwenka,et al.  Regulatory T cells control macrophage accumulation and activation in lymphoma , 2009, International journal of cancer.

[42]  David J. Yang,et al.  Innate immune functions of microglia isolated from human glioma patients , 2006, Journal of Translational Medicine.

[43]  Y. Fukuuchi,et al.  Microglia-specific localisation of a novel calcium binding protein, Iba1. , 1998, Brain research. Molecular brain research.

[44]  E F Heineman,et al.  Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. , 1999, Journal of the National Cancer Institute.

[45]  W. Roggendorf,et al.  Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study , 2001, Acta Neuropathologica.

[46]  Michael E. Berens,et al.  Molecular Mechanisms of Glioma Cell Migration and Invasion , 2004, Journal of Neuro-Oncology.

[47]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[48]  C. Wood,et al.  Expression of interleukin-11 and its encoding mRNA by glioblastoma cells , 1995, Neuroscience Letters.

[49]  J. Tonn,et al.  Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. , 1997, Anticancer research.

[50]  B. Scheithauer,et al.  Microglia in brain tumors , 2002, Glia.

[51]  H. Budka,et al.  Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation , 2004, Acta Neuropathologica.

[52]  J. Lafuente,et al.  Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas. , 1999, Journal of molecular neuroscience : MN.

[53]  W. Streit,et al.  Reactive microgliosis , 1999, Progress in Neurobiology.

[54]  L. D.,et al.  Brain tumors , 2005, Psychiatric Quarterly.

[55]  V. Najjar,et al.  The chemical synthesis of the phagocytosis-stimulating tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and its biological properties. , 1973, Biochimica et biophysica acta.

[56]  K. Frei,et al.  Microglia and tumor rejection. , 1994, Neuropathology and applied neurobiology.

[57]  Linet,et al.  RESPONSE: Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality. , 1999, Journal of the National Cancer Institute.

[58]  W. Hiddemann,et al.  Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia. , 1999, Experimental hematology.

[59]  B. Becher,et al.  Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.

[60]  B. Badie,et al.  In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. , 1999, Neurosurgery.

[61]  R. Weichselbaum,et al.  Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy. , 2010, Cancer research.

[62]  R. Alterman,et al.  Colony stimulating factor-1 expression in human glioma , 1994, Molecular and chemical neuropathology.

[63]  H. Boddeke,et al.  Vesicle-Mediated Transport and Release of CCL21 in Endangered Neurons: A Possible Explanation for Microglia Activation Remote from a Primary Lesion , 2005, The Journal of Neuroscience.

[64]  W. Paulus,et al.  Distribution and characterization of microglia/macrophages in human brain tumors , 1996, Acta Neuropathologica.

[65]  C. Beaudry,et al.  MAP-ing glioma invasion: Mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival , 2007, Molecular Cancer Therapeutics.

[66]  P. Rieckmann,et al.  Microglial/macrophage expression of interleukin 10 in human glioblastomas , 1999, International journal of cancer.

[67]  S. Leung,et al.  Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas , 1997, Acta Neuropathologica.

[68]  W. Hamel,et al.  Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model , 2010, Cancer Immunology, Immunotherapy.

[69]  D. Mitchell,et al.  Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens , 1992, Brain Research.

[70]  Melody A. Swartz,et al.  Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21 , 2010, Science.

[71]  Nico van Rooijen,et al.  Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2 , 2005, Journal of neuropathology and experimental neurology.

[72]  K. Stocka,et al.  Gliomas induce and exploit microglial MT 1-MMP expression for tumor expansion , 2009 .

[73]  A. Sonabend,et al.  Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors , 2006, Glia.

[74]  G. Gillespie,et al.  Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. , 1995, Journal of Neurosurgery.